Evidence map›Paper›PMID 35066884›Full record

ArticleJournal of surgical oncology2022

Transcervical inflatable mediastinoscopic esophagectomy versus thoracoscopic esophagectomy for local early- and intermediate-stage esophageal squamous cell carcinoma: A propensity score-matched analysis.

Zihao Chen, Kenan Huang, Rongqiang Wei, Chengdong Liu, Yunhao Fang, Bin Wu, Zhifei Xu, Xinyu Ding, Hua Tang

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of surgical oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 2 pooled it
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 2 syntheses or guidelines pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Zihao ChenDepartment of Minimally Invasive Thoracic Surgery Center, Second Affiliated Hospital of Naval Medical University, Shanghai, China.ORCID http://orcid.org/0000-0002-7560-8243
Kenan HuangDepartment of Minimally Invasive Thoracic Surgery Center, Second Affiliated Hospital of Naval Medical University, Shanghai, China.
Rongqiang WeiDepartment of Minimally Invasive Thoracic Surgery Center, Second Affiliated Hospital of Naval Medical University, Shanghai, China.
Chengdong LiuDepartment of Minimally Invasive Thoracic Surgery Center, Second Affiliated Hospital of Naval Medical University, Shanghai, China.ORCID http://orcid.org/0000-0001-9357-7797
Yunhao FangDepartment of Minimally Invasive Thoracic Surgery Center, Second Affiliated Hospital of Naval Medical University, Shanghai, China.
Bin WuDepartment of Thoracic Surgery, Second Affiliated Hospital of Naval Medical University, Shanghai, China.
Zhifei XuDepartment of Minimally Invasive Thoracic Surgery Center, Second Affiliated Hospital of Naval Medical University, Shanghai, China.
Xinyu DingDepartment of Minimally Invasive Thoracic Surgery Center, Second Affiliated Hospital of Naval Medical University, Shanghai, China.
Hua TangDepartment of Minimally Invasive Thoracic Surgery Center, Second Affiliated Hospital of Naval Medical University, Shanghai, China.ORCID http://orcid.org/0000-0002-7132-960X
Second Military Medical University · CNShanghai Changzheng Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

objectiveTranscervical inflatable mediastinoscopic esophagectomy (TIME) is a novel method of minimally invasive esophagectomy (MIE) for esophageal cancer. However, whether TIME is effective and feasible as conventional MIE remains unclear. This study aimed to evaluate the efficacy of TIME by comparing it with thoracoscopic esophagectomy (TE).

methodsSurgical outcomes and relapse-free survival (RFS) rates of patients with local early- or intermediate-stage thoracic esophageal squamous cell carcinoma that underwent TIME or TE from January 2017 to December 2019 were analyzed in this retrospective study. Propensity score matching was used to control the confounding factors.

resultsThe mean operation time in TIME was shorter than that in TE (p < 0.05). Patients in the TIME group achieved postoperative ambulation earlier than those in the TE group (p < 0.05). The rate of pulmonary complications was lower in TIME than in TE (p < 0.05). The number of lymph nodes harvested during surgery and the RFS rates of two groups did not have significant differences.

conclusionTIME may be a feasible and safe method to treat local early- and intermediate-stage thoracic esophageal squamous cell carcinoma effectively and it could be a supplementary surgical method of TE for patients with poor pulmonary function or cannot undergo TE.

Indexed as

Esophageal NeoplasmsEsophageal Squamous Cell CarcinomaEsophagectomyHumansPostoperative ComplicationsPropensity ScoreRetrospective StudiesThoracoscopyTreatment Outcomeesophageal cancerminimally invasive esophagectomythoracoscopic esophagectomytranscervical inflatable mediastinoscopic esophagectomy

Identifiers

PMID35066884
PMCPMC9304140
OpenAlexW4206972033

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.